Influence of Breakfast Consumption on Chlorogenic Acid Metabolism in Humans
NCT ID: NCT01523028
Last Updated: 2013-06-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
14 participants
INTERVENTIONAL
2011-09-30
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bioavailability of Chlorogenic and Phenolic Acids From Soluble Coffees
NCT01400386
Coffee Polyphenols Antioxidants
NCT01832662
Coffee, Exercise, and Oxidative Stress
NCT01832701
Absorption of Phenolic Acids From Coffee in Humans
NCT01912144
Dose Response Bioavailability of Coffee and Green Tea Antioxidants in Humans
NCT01089920
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Coffee, bread and honey
200 mL coffee + 2 bread rolls + honey
Soluble Coffee
Amounts of chlorogenic acids will be normalized to body weight (3.1 mg CA / kg BW). Coffee will be reconstituted in 200 mL hot water and consumed 3 times in a row (min 1-week interval), alone or with a breakfast:
* 200 mL coffee or
* 200 mL coffee + 2 bread rolls + honey
* 200 mL coffee + 1 bread roll + peanut butter
Coffee, bread and peanut butter
200 mL coffee + 1 bread roll + peanut butter
Soluble Coffee
Amounts of chlorogenic acids will be normalized to body weight (3.1 mg CA / kg BW). Coffee will be reconstituted in 200 mL hot water and consumed 3 times in a row (min 1-week interval), alone or with a breakfast:
* 200 mL coffee or
* 200 mL coffee + 2 bread rolls + honey
* 200 mL coffee + 1 bread roll + peanut butter
200 mL black coffee
Soluble Coffee
Amounts of chlorogenic acids will be normalized to body weight (3.1 mg CA / kg BW). Coffee will be reconstituted in 200 mL hot water and consumed 3 times in a row (min 1-week interval), alone or with a breakfast:
* 200 mL coffee or
* 200 mL coffee + 2 bread rolls + honey
* 200 mL coffee + 1 bread roll + peanut butter
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Soluble Coffee
Amounts of chlorogenic acids will be normalized to body weight (3.1 mg CA / kg BW). Coffee will be reconstituted in 200 mL hot water and consumed 3 times in a row (min 1-week interval), alone or with a breakfast:
* 200 mL coffee or
* 200 mL coffee + 2 bread rolls + honey
* 200 mL coffee + 1 bread roll + peanut butter
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 20-44 years
* Caucasian origin
* Body mass index (BMI) 19-25 kg/m2
* Used to drinking coffee (similar to study coffee) on a daily basis
* Being able to tolerate a 48-hour coffee abstinence
* Normal oral glucose tolerance test
* Having signed the informed consent form
Exclusion Criteria
* Smoking
* Performing a competitive sport
* Having metabolic disorders
* Long gut transit time (\>24 h)
* Blood donor
* Irregularity in menstrual cycle (for women)
* Pregnancy (for women)
* Subject who cannot be expected to comply with the study procedures.
* Currently participating or having participated in another clinical trial during the last 4 weeks prior to the beginning of this study.
20 Years
44 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Société des Produits Nestlé (SPN)
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Kaiserslautern
Kaiserslautern, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11.12.NRC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.